Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1894 1
1911 1
1916 1
1919 1
1925 1
1933 2
1934 1
1936 1
1937 1
1947 5
1948 3
1949 2
1950 5
1951 3
1952 1
1953 5
1954 3
1955 2
1956 4
1957 1
1958 4
1959 6
1960 5
1961 6
1962 4
1963 7
1964 9
1965 5
1966 14
1967 10
1968 10
1969 16
1970 18
1971 31
1972 20
1973 83
1974 119
1975 285
1976 336
1977 350
1978 347
1979 364
1980 367
1981 426
1982 475
1983 562
1984 685
1985 677
1986 758
1987 753
1988 795
1989 889
1990 1017
1991 1067
1992 1198
1993 1406
1994 1273
1995 1223
1996 1309
1997 1357
1998 1195
1999 1195
2000 1360
2001 1336
2002 1382
2003 1510
2004 1715
2005 2054
2006 2040
2007 2056
2008 2297
2009 2284
2010 2383
2011 2653
2012 2872
2013 3049
2014 3352
2015 3411
2016 3350
2017 3303
2018 3267
2019 3388
2020 3537
2021 3326
2022 3039
2023 2789
2024 3139
2025 3527
2026 2455
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83,573 results

Results by year

Filters applied: . Clear all
Page 1
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.
Horowitz MA, Jauhar S, Natesan S, Murray RM, Taylor D. Horowitz MA, et al. Schizophr Bull. 2021 Jul 8;47(4):1116-1129. doi: 10.1093/schbul/sbab017. Schizophr Bull. 2021. PMID: 33754644 Free PMC article.
The process of stopping antipsychotics may be causally related to relapse, potentially linked to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity. Therefore, the risk of relapse on cessation of antipsychotics may be minimized by …
The process of stopping antipsychotics may be causally related to relapse, potentially linked to neuroadaptations that persist after cess …
Cessation of Anti-VEGF Treatment Therapy in Age-Related Macular Degeneration: A Narrative Review.
Usmani E, Bahrami B, Ebneter A, Chan WO. Usmani E, et al. Clin Exp Ophthalmol. 2026 Mar;54(2):275-283. doi: 10.1111/ceo.70034. Epub 2025 Nov 13. Clin Exp Ophthalmol. 2026. PMID: 41230723 Review.
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionised the treatment of neovascular age-related macular degeneration (nAMD), significantly improving visual outcomes and enhancing the quality of life for affected patients. ...This …
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionised the treatment of neovascular age-r …
Ertapenem-induced encephalopathy.
Adams R, Chopra P, Miranda R, Calderon A. Adams R, et al. BMJ Case Rep. 2020 Jun 1;13(6):e231875. doi: 10.1136/bcr-2019-231875. BMJ Case Rep. 2020. PMID: 32487528 Free PMC article.
This patient is a middle-aged Caucasian man who received intravenous ertapenem for treatment of empyema. Although the empyema improved, he developed delirium beginning on day 7 of ertapenem. ...No improvement in mental status was observed with cessation of other med …
This patient is a middle-aged Caucasian man who received intravenous ertapenem for treatment of empyema. Although the empyema improve …
Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation.
Tseng TN, Jeng WJ, Hu TH, Wang JH, Hung CH, Lu SN, Chen CH. Tseng TN, et al. J Antimicrob Chemother. 2023 Feb 1;78(2):436-439. doi: 10.1093/jac/dkac409. J Antimicrob Chemother. 2023. PMID: 36478233 Free article.
BACKGROUND: For patients with chronic hepatitis B (CHB), the optimal stopping criteria for entecavir or tenofovir disoproxil fumarate treatment remain unclear. METHODS: This study recruited CHB patients with levels of hepatitis B surface antigen (HBsAg) <100 IU/mL at th …
BACKGROUND: For patients with chronic hepatitis B (CHB), the optimal stopping criteria for entecavir or tenofovir disoproxil fumarate tre …
Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O. Welsh JW, et al. Drug Alcohol Depend. 2018 Aug 1;189:96-107. doi: 10.1016/j.drugalcdep.2018.04.028. Epub 2018 May 31. Drug Alcohol Depend. 2018. PMID: 29906718 Review.
METHODS: A PubMed literature search was conducted using the medical subject heading of benzodiazepines in combination with the following key words: discontinuation, withdrawal, detoxification, cessation, dependence, addiction, substance use disorders, or long term. Twenty- …
METHODS: A PubMed literature search was conducted using the medical subject heading of benzodiazepines in combination with the following key …
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.
Mohareb AM, Ezaz G, Kim AY, Freedberg KA, Boyd A, Hyle EP. Mohareb AM, et al. J Viral Hepat. 2025 Oct;32(10):e70079. doi: 10.1111/jvh.70079. J Viral Hepat. 2025. PMID: 40923770 Free PMC article.
We developed a Markov state model with Monte Carlo simulation of chronic HBV to compare continuation of antiviral therapy with 3 strategies of cessation and reinitiation for: (1) virologic relapse, (2) clinical relapse, or (3) hepatitis flare. ...In an undifferentia …
We developed a Markov state model with Monte Carlo simulation of chronic HBV to compare continuation of antiviral therapy with 3 stra …
Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome.
Mazlan-Kepli W, Dawson J, Berry C, Walters M. Mazlan-Kepli W, et al. Heart. 2019 Jan;105(1):67-74. doi: 10.1136/heartjnl-2018-313148. Epub 2018 Jul 20. Heart. 2019. PMID: 30030335 Free article.
OBJECTIVE: To assess whether cardiovascular events are increased after cessation of dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) and to explore predictors for recurrent events after DAPT cessation during long-term follow-up. ...CON …
OBJECTIVE: To assess whether cardiovascular events are increased after cessation of dual antiplatelet therapy (DAPT) following …
Effects of treatment cessation and re-treatment in randomized controlled trials of prucalopride in patients with chronic idiopathic constipation.
Hinson J, Achenbach H, Terreri B, Boules M. Hinson J, et al. Neurogastroenterol Motil. 2023 Jul;35(7):e14563. doi: 10.1111/nmo.14563. Epub 2023 Apr 3. Neurogastroenterol Motil. 2023. PMID: 37010859
BACKGROUND: Prucalopride is a selective, high-affinity serotonin type 4 receptor agonist approved for the treatment of chronic idiopathic constipation (CIC) in adults. We investigated the impact of prucalopride cessation and re-treatment on efficacy and safet …
BACKGROUND: Prucalopride is a selective, high-affinity serotonin type 4 receptor agonist approved for the treatment of chronic idiopa …
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Fletcher K, Cortellini A, Ganta T, Kankaria R, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Presley CJ, Owen DH, Abou Alaiwi S, Nassar AH, Lamberti G, Perrone F, Buti S, Giusti R, Filetti M, Vanella V, Mallardo D, Sussman TA, Galetta D, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Nebhan C, Berg S, Choueiri TK, Marron TU, Wang Y, Naqash AR, Johnson DB. Fletcher K, et al. Cancer Lett. 2024 Aug 1;596:217001. doi: 10.1016/j.canlet.2024.217001. Epub 2024 Jun 3. Cancer Lett. 2024. PMID: 38838764 Free article.
Older patients have similar immune checkpoint inhibitor efficacy and rates of adverse events as younger patients, but appear to have decreased tolerability, particularly in the oldest patient cohort (>80 years), often leading to early cessation of therapy. We aim …
Older patients have similar immune checkpoint inhibitor efficacy and rates of adverse events as younger patients, but appear to have decreas …
The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy.
Hall S, Howell J, Visvanathan K, Thompson A. Hall S, et al. Viruses. 2020 Aug 25;12(9):934. doi: 10.3390/v12090934. Viruses. 2020. PMID: 32854335 Free PMC article. Review.
They effectively suppress HBV replication to reduce the risk of cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Treatment is continued long-term in most patients, as NA therapy rarely induces HBsAg loss or functional cure. ...In LMICs, this strategy ma …
They effectively suppress HBV replication to reduce the risk of cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Treatment …
83,573 results
You have reached the last available page of results. Please see the User Guide for more information.